Assessment of time from cytoreductive nephrectomy (CN) to initiation of targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC).

Winston Vuong, Sumanta Kumar Pal, Nora Ruel et al.|Journal of Clinical Oncology|2014

Cited by 0